MannKind to Present at the UBS Global Life Sciences Conference

Wednesday, September 19, 2007 General News
Email Print This Page Comment bookmark
Font : A-A+

VALENCIA, Calif., Sept. 18 MannKind Corporation(Nasdaq: MNKD), focused on discovering, developing and commercializingtreatments for diabetes and cancer, announced today that it will present atthe UBS Global Life Sciences Conference on September 25, 2007 at 10:30 AM ETat the Grand Hyatt Hotel in New York, NY.

Interested parties can access a link to the live web cast of thepresentation in the Investor Relations section of the Company's website athttp://www.mannkindcorp.com. A replay of the presentation will be availablefor 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, developmentand commercialization of therapeutic products for diseases such as diabetesand cancer. Its lead product, the Technosphere(R) Insulin System, iscurrently in phase 3 clinical trials in the United States, Europe and LatinAmerica to study its safety and efficacy in the treatment of diabetes. Formore information on MannKind Corporation and its technology, visithttp://www.mannkindcorp.com.

SOURCE MannKind Corporation


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook